Bioaerosol emissions during toilet flushing are an often-overlooked source of potential health risks in shared public facilities. A new study published in Risk Analysis found that bioaerosol concentrations of two bacteria—Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus)—exceeded acceptable levels established by the Centers for Disease Control (CDC) after toilet flushing. Inhaling these biological particles can produce symptoms like abdominal cramps, nausea, diarrhea, and vomiting.
Global action needed to solve the medical oxygen crisis, report suggests
Targets for universal access, national roadmaps and more affordable and accessible care are vital to help fill the medical oxygen gap affecting more than half of the world’s population, according to a new global report.
Remotely-delivered dementia care: A cost-effective solution for personalized support at home
The NIDUS-Family package of care uses goal setting to help people with dementia live well at home for longer. New research from Queen Mary University of London in collaboration with UCL shows that, in addition to these known benefits, NIDUS-Family also reduces the costs associated with providing support to people with dementia.
Light-activated dyes show promise in targeting cancer cells
Melanoma is one of the most aggressive skin cancers, with more than 300,000 new cases reported worldwide each year. In Europe, the number of diagnoses has been rising rapidly. However, early detection and advanced treatments can significantly improve survival rates.
Obesity and medication: When does bodyweight matter?
How can we best treat infectious diseases in people with obesity? Hospital pharmacist and Ph.D. researcher Koen van Rhee studied how obesity affects blood levels of two commonly used medicines. He also developed a method for pharmaceutical companies to test new drugs on this patient group.
Colorado has ‘very high’ flu activity, but not as bad as the rest of the country
The flu is widespread in Colorado, but the virus hasn’t hit the state nearly as hard as some others.
What are the side effects of GLP-1 medications? A researcher explains
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings. However, over the past few years, these medications have become popular due to their weight loss and weight management benefits. Dr. Saundra Nguyen, assistant professor of internal medicine at Baylor College of Medicine, explains the side effects of GLP-1s.
Next-generation degradable 3D meshes offer hope for pelvic organ prolapse repair
A debilitating condition affecting 1 in 4 women is desperately crying out for a solution, and the next generation of treatments to repair the damage of pelvic organ prolapse (POP) has just come a big step closer.
Genetic study links defects in sugar digestion to irritable bowel syndrome
Sucrase-isomaltase (SI) is an intestinal enzyme critical for the digestion of dietary carbohydrates, particularly sucrose and starch. Previous studies from the Gastrointestinal Genetics team at CIC bioGUNE—BRTA and LUM University suggested a genetic link between SI defects and IBS, whereby certain DNA changes cause reduced enzymatic activity and inefficient digestion of carbohydrates, thus inducing symptoms like bloating, diarrhea, and abdominal pain.
Surgeons detail challenges in treating ‘tranq’ wounds amid Philadelphia’s Xylazine crisis
A new study examining the treatment of xylazine-associated wounds in Philadelphia sheds light on the severe medical complications and health care challenges caused by the widespread presence of the drug in the city’s illicit supply.